GCP intratumoral catheter for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Apr 2023: Trial registered, NCT05835804

The trials

NCT05835804: Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers

State
Not started
Phase
Phase 2
People
39 planned
Started
Nov 2025
Primary completion
Apr 2026
Arms
Intratumoral chemotherapy
Results
None posted
  1. 28 Apr 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.